ACTG Presents Data from MPOX Study STOMP at CROI
The AIDS Clinical Trials Group (ACTG) presented data from the STOMP trial at the 2025 Conference on Retroviruses and...
The AIDS Clinical Trials Group (ACTG) presented data from the STOMP trial at the 2025 Conference on Retroviruses and...
Rakovina Therapeutics has received its first synthesized batch of AI-generated ATR inhibitor compounds, developed in partnership with Variational AI....
Clene Inc. announced positive results from a new analysis of the HEALEY ALS Platform Trial data. The analysis showed...
MSInsight, a precision oncology start-up, secured €1.6 million in seed funding from Calyseed, angel investors, and banking partners including...
Valo Therapeutics Oy secured €19 million in funding to advance the clinical development of its lead cancer immunotherapy candidate,...
The AIDS Clinical Trials Group (ACTG) presented findings from their SLIM LIVER study at the 2025 Conference on Retroviruses...
Eradivir, a clinical-stage immunotherapy company, launched a Phase 2 challenge study for its antiviral therapeutic, EV25, to evaluate its...
Calidi Biotherapeutics announced preclinical success with its systemic RTNova platform, demonstrating effective delivery of gene therapy payloads to targeted...
Tonix Pharmaceuticals has received a grant from the Medical CBRN Defense Consortium (MCDC) to further develop TNX-801, a single-dose...
TG Therapeutics announced upcoming presentations of Briumvi (ublituximab-xiiy) data for relapsing multiple sclerosis (RMS) at the American Academy of...